These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23706090)

  • 1. A proteomic view of isoproterenol induced cardiac hypertrophy: prohibitin identified as a potential biomarker in rats.
    Chowdhury D; Tangutur AD; Khatua TN; Saxena P; Banerjee SK; Bhadra MP
    J Transl Med; 2013 May; 11():130. PubMed ID: 23706090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
    Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
    PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiomyocyte Proteome Remodeling due to Isoproterenol-Induced Cardiac Hypertrophy during the Compensated Phase.
    Parreira RC; Gómez-Mendoza DP; de Jesus ICG; Lemos RP; Santos AK; Rezende CP; Figueiredo HCP; Pinto MCX; Kjeldsen F; Guatimosim S; Resende RR; Verano-Braga T
    Proteomics Clin Appl; 2020 Jul; 14(4):e2000017. PubMed ID: 32506788
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Kumari S; Katare PB; Elancheran R; Nizami HL; Paramesha B; Arava S; Sarma PP; Kumar R; Mahajan D; Kumar Y; Devi R; Banerjee SK
    Oxid Med Cell Longev; 2020; 2020():7147498. PubMed ID: 32082481
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol.
    Maayah ZH; Althurwi HN; El-Sherbeni AA; Abdelhamid G; Siraki AG; El-Kadi AO
    Mol Cell Biochem; 2017 May; 429(1-2):151-165. PubMed ID: 28251434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The poly(ADP-ribosyl)ation of FoxO3 mediated by PARP1 participates in isoproterenol-induced cardiac hypertrophy.
    Lu J; Zhang R; Hong H; Yang Z; Sun D; Sun S; Guo X; Ye J; Li Z; Liu P
    Biochim Biophys Acta; 2016 Dec; 1863(12):3027-3039. PubMed ID: 27686254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cymbopogon Proximus Essential Oil Protects Rats against Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis.
    Althurwi HN; Abdel-Kader MS; Alharthy KM; Salkini MA; Albaqami FF
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32295062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragalus polysaccharide attenuates isoproterenol-induced cardiac hypertrophy by regulating TNF-α/PGC-1α signaling mediated energy biosynthesis.
    Luan A; Tang F; Yang Y; Lu M; Wang H; Zhang Y
    Environ Toxicol Pharmacol; 2015 May; 39(3):1081-90. PubMed ID: 25880160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of proteins responding to adrenergic receptor subtype-specific hypertrophy in cardiomyocytes by proteomic approaches.
    Liu N; Gong KZ; Cai YB; Li Z
    Biochemistry (Mosc); 2011 Oct; 76(10):1140-6. PubMed ID: 22098239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G3BP2 is involved in isoproterenol-induced cardiac hypertrophy through activating the NF-κB signaling pathway.
    Hong HQ; Lu J; Fang XL; Zhang YH; Cai Y; Yuan J; Liu PQ; Ye JT
    Acta Pharmacol Sin; 2018 Feb; 39(2):184-194. PubMed ID: 28816235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats.
    Zordoky BN; Aboutabl ME; El-Kadi AO
    Drug Metab Dispos; 2008 Nov; 36(11):2277-86. PubMed ID: 18725507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betulinic Acid Improves Cardiac-Renal Dysfunction Caused by Hypertrophy through Calcineurin-NFATc3 Signaling.
    Hong MH; Na SW; Jang YJ; Yoon JJ; Lee YJ; Lee HS; Kim HY; Kang DG
    Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AdipoRon prevents l-thyroxine or isoproterenol-induced cardiac hypertrophy through regulating the AMPK-related pathway.
    Hu X; Ou-Yang Q; Wang L; Li T; Xie X; Liu J
    Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):20-30. PubMed ID: 30566571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of the protective effects of aqueous bark extract of Terminalia arjuna (Roxb.) on isoproterenol-induced cardiac hypertrophy in rats.
    Kumar S; Jahangir Alam M; Prabhakar P; Ahmad S; Maulik SK; Sharma M; Goswami SK
    J Ethnopharmacol; 2017 Feb; 198():98-108. PubMed ID: 28063919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway.
    Al-Rasheed NM; Al-Oteibi MM; Al-Manee RZ; Al-Shareef SA; Al-Rasheed NM; Hasan IH; Mohamad RA; Mahmoud AM
    Drug Des Devel Ther; 2015; 9():3217-29. PubMed ID: 26150695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained increased CaMKII phosphorylation is involved in the impaired regression of isoproterenol-induced cardiac hypertrophy in rats.
    Li J; Gao Q; Wang S; Kang Z; Li Z; Lei S; Sun X; Zhao M; Chen X; Jiao G; Hu H; Hao L
    J Pharmacol Sci; 2020 Sep; 144(1):30-42. PubMed ID: 32665128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1- and isoproterenol-induced differential protein expression and signaling pathway in HL-1 cardiomyocytes.
    Hong HM; Song EJ; Oh E; Kabir MH; Lee C; Yoo YS
    Proteomics; 2011 Jan; 11(2):283-97. PubMed ID: 21204255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway.
    Fang X; Liu Y; Lu J; Hong H; Yuan J; Zhang Y; Wang P; Liu P; Ye J
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1373-1385. PubMed ID: 30132020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aurintricarboxylic acid protects isoproterenol induced left ventricular hypertrophy by modulating TWEAK signaling.
    Burman P; Jaiswal R; Devi K; Moharana B
    Cardiovasc Pathol; 2022; 61():107468. PubMed ID: 35977688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canstatin suppresses isoproterenol-induced cardiac hypertrophy through inhibition of calcineurin/nuclear factor of activated T-cells pathway in rats.
    Sugiyama A; Okada M; Yamawaki H
    Eur J Pharmacol; 2020 Mar; 871():172849. PubMed ID: 31843516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.